News
MNTA
--
0.00%
--
STOCKHOLDER ALERT: Monteverde & Associates is Investigating the Following Mergers
ACCESSWIRE · 4d ago
Top Pharmaceutical Stocks for Q4 2020
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2020.
Investopedia · 4d ago
Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson
CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced the expiration of the waiting
GlobeNewswire · 5d ago
Why Is Momenta (MNTA) Up 86.9% Since Last Earnings Report?
Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 09/09 16:30
Plasma-Centric Drugmaker Grifols To Buy Geriatric Pharma Startup Alkahest
Blood plasma and diagnostics company Grifols SA (NASDAQ: GRFS) is set to completely acquire Alkahest Inc, a biopharmaceutical startup focussed on neurodegenerative and age-related diseases, for $146 million on a debt-free basis.
Benzinga · 09/08 06:17
Hedge Funds Cant Buy Enough Of Momenta Pharmaceuticals, Inc. (MNTA)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually
Insider Monkey · 09/07 17:36
2 Top Coronavirus Vaccine Stocks to Buy When the Next Market Crash Comes
MotleyFool.com · 09/04 06:37
Covid-19 Has Priced These Stocks at a Deep Discount
As Covid shut down large swaths of the non-digital economy, investors dumped stocks whose sales suffered most directly. But now the market seems willing to look ahead to these businesses’ revivals.
Barrons.com · 09/03 10:00
Immunovant, Following Rival's Acquisition News, Prices Stock Offering
Investor's Business Daily · 09/02 14:39
J&J's Janssen said Phase 3 trial showed pimodivir was 'very unlikely' to demonstrate added benefit
marketwatch.com · 09/02 13:17
Surge in megadeals points to M&A recovery as tech sector dominates
marketwatch.com · 09/01 12:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm MNTA, RST, AIMT, BYFC
ACCESSWIRE · 08/31 22:55
3 Stocks to Buy and Hold for Decades
MotleyFool.com · 08/30 06:17
GW Pharmaceuticals, Momenta Pharmaceuticals and Zogenix all started at market perform at Raymond James
MNTA | Complete Momenta Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
marketwatch.com · 08/25 12:17
Wall Street Breakfast: The Week Ahead
Seeking Alpha - Article · 08/22 12:50
Housing Numbers Rise, and Lowe’s and Home Depot Follow
Low interest rates and suburban refuges from Covid-19 are driving housing starts. Some indirect beneficiaries: the home-improvement chains. But how long will...
marketwatch.com · 08/21 23:11
Wall Street Breakfast: Global Markets Churn Higher On Vaccine Hopes
Seeking Alpha - Article · 08/21 10:54
Johnson & Johnson Borrows $7.5B To Fund Its Purchase Of Momenta
Johnson & Johnson (NYSE: JNJ) is borrowing $7.5 billion in bonds to help fund its purchase of Momenta Pharmaceuticals, Inc (NASDAQ: MNTA) as a series of companies tap the debt market to finance merger and acquisitions, Bloomberg reported Thursday.What Happened The multinational drugmaker sold debt in
Benzinga · 08/21 04:10
Johnson & Johnson adds to debt frenzy, borrows $7.5 billion to buy Momenta
J&J is seizing on cheap pandemic funding available in the booming U.S. corporate bond market to raise enough money to pay for its acquisition of Momenta, and...
marketwatch.com · 08/21 00:32
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Momenta Pharmaceuticals, Inc. to Johnson & Johnson
New York, New York--(Newsfile Corp. - August 20, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Momenta Pharmaceuticals, Inc. ("Momenta" or the "Company") (NASDAQ: MNTA) stock prior to August 19, 2020.You are hereby
Newsfile · 08/20 21:44